申请人:Merk Frosst Canada & Co.
公开号:US06225288B1
公开(公告)日:2001-05-01
Compounds represented by formula I:
as well as pharmaceutically acceptable salts, esters and hydrates thereof are disclosed along with pharmaceutical compositions and methods of treatment. The compounds are useful as inhibitors of caspase-3, which is implicated in modulating apoptosis.
由式I表示的化合物,以及其药学上可接受的盐、酯和水合物,以及配制的药物组合物和治疗方法被揭示。这些化合物可用作caspase-3的抑制剂,该酶参与调节细胞凋亡。